Future Directions for Laboratory Animal Law in the United States January 26, 2018 Wasserstein Hall, Milstein East (2036) Harvard Law School, 1585 Massachusetts Ave., Cambridge, MA Please join the ILAR Roundtable, the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School, and the Animal Law and Policy Program at Harvard Law School for a one-day meeting to…
By Gali Katznelson Two weeks ago, Sophia, a robot built by Hanson Robotics, was ostensibly granted citizenship in Saudi Arabia. Sophia, an artificially intelligent (AI) robot modelled after Audrey Hepburn, appeared on stage at the Future Investment Initiative Conference in Riyadh to speak to CNBC’s Andrew Ross Sorkin, thanking the Kingdom of Saudi Arabia for naming her…
By Nir Eyal Last week, over 200 experts called on the next Director General of the World Health Organization to prioritize factory farming in an open letter. Announced in articles in the New York Times and The Lancet, the letter argues that factory farming is a major barrier to better global health. The letter does not make this argument…
By Brad Segal In January of this year, Cell published a study modestly titled, Interspecies Chimerism with Mammalian Pluripotent Stem Cells. It reports success bioengineering a mostly-pig partly-human embryo. One day before, Nature published a report that scientists had grown (for lack of a better word) a functioning genetically-mouse pancreas within the body of a…
By I. Glenn Cohen [WARNING: Spoilers below] On Sunday, HBO’s Westworld finished its run. Though I thought some of the early episodes were arguably a bit of a failure as television (and my partner almost jumped off the bandwagon of making this one of “our shows”) IMHO the show finished very strong. But whatever you…
By Wendy S. Salkin Two investor class-action suits have been filed within days of one another against two different California-based pharmaceutical companies both of which produce hepatitis B treatments, Dynavax Technologies and Arrowhead Pharmaceuticals. The named plaintiffs in both shareholder class-action suits, David Soontjens and Yaki J. Meller, are represented by counsel at Pomerantz, LLP.[1] Meller…
By Seán Finan Last week, a patent application in India was refused, apparently on the basis that the invention under review could have been used to counterfeit money. This practice of denying patents on the basis of public policy or morality is almost as old as the practice of granting patents. For example, the State of Monopolies…
By I. Glenn Cohen As reported by Science, today the NIH announced plans to lift a preemptive year long moratorium on funding chimera research – that which mixes human and animal cells, often at the embryonic stage. Here is a snippet from the Science article about the new proposed NIH process: According to two notices released today, NIH is…
Non-Human Primates in Research: Legal and Ethical Considerations September 30, 2015, 12:00 PM Wasserstein Hall, Room 1010 Harvard Law School, 1585 Massachusetts Ave., Cambridge, MA [Map] Description: Please join us for a discussion of critical legal, ethical, scientific, and social issues raised by research involving non-human primates, and the research centers that house them. What does…
Non-Human Primates in Research: Legal and Ethical Considerations September 30, 2015, 12:00 PM Wasserstein Hall, Room 1010 Harvard Law School, 1585 Massachusetts Ave., Cambridge, MA [Map] Description: Please join us for a discussion of critical legal, ethical, scientific, and social issues raised by research involving non-human primates, and the research centers that house them. …
